Friday, January 23, 9:35 am – 10:05 am

Expanded PNS Options with TD2: Enabling Targeted Therapy for Diverse Pain Presentations

The newly enhanced therapy disc – TD2 – enables even greater flexibility in placement due to its smaller size. This modification further enhances the versatility of the Nalu Therapy System empowering clinicians to tailor treatment to individual anatomical needs, while maintaining its proven performance and reliability.

*Paid consultant of Nalu Medical, Inc.

Saturday, January 24, 12:30 pm – 1:00 pm

Evolving Approaches to Peripheral Pain: Expanding Nalu Use with Medial Branch Targeting

Peripheral nerve stimulation (PNS) is advancing rapidly, with new anatomical targets like lumbar and cervical medial branch opening doors to tailored pain management. The versatility of the Nalu Therapy System enables clinicians to explore and adopt these emerging approaches, adapting therapy to the unique needs of each patient and expanding patient care.

*Paid consultant of Nalu Medical, Inc.

Saturday January 24, 10:55 AM -11:05 AM
Neopolitan Ballroom I & II

Pain Outcomes from the COMFORT 2 RCT for Peripheral Nerve Stimulation – 12-Month Results

&nbsp
Hear the latest 12-month results from the COMFORT 2 clinical trial.

Join us at this NANS 2026 podium session to hear long-term data from COMFORT 2, a multicenter randomized controlled trial evaluating PNS and CMM versus CMM alone for chronic peripheral nerve pain.

Interim findings show 70% average pain relief and an 85% responder rate at 12 months.
Don’t miss this in-depth look at the methodology, outcomes, and what’s next as follow-up continues to 36 months.

*Paid consultant of Nalu Medical, Inc.